Paper Review Records
全部论文审稿周期
26 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
122
天
Immune potentiating effects of the HDAC inhibitor Zabadinostat on human immune and tumor cells
作者
Stephanie C. Pitts; Carolina Celades; Nicole J. Toney; Megan T. Lynch; Natalie F. McMyn; Lisa K. Poppe; Shantel Angstadt; Claudia Palena; Thomas J. Meyer; Margaret Cam; Patrick Soon‐Shiong; Nicholas B. La Thangue; David Kerr; Sofia R. Gameiro; Jeffrey Schlom; Renee N. Donahue展开收起
作者单位
1. Center for Immuno‐Oncology, Center for Cancer Research National Cancer Institute, National Institutes of Health Bethesda Maryland USA; 2. CCR Collaborative Bioinformatics Resource, Center for Cancer Research National Cancer Institute, National Institutes of Health Bethesda Maryland USA; 3. ImmunityBio San Diego California USA; 4. IngenOx Therapeutics Oxford UK展开收起
286
天
Osimertinib resistance in non‐small cell lung cancer is mediated by sustained AKT activation through lipid raft‐dependent insulin signaling
作者
Yen‐Lin Lai; Jin‐Yuan Shih; Ching‐Chow Chen展开收起
作者单位
1. Department and Graduate Institute of Pharmacology, College of Medicine National Taiwan University Taipei Taiwan; 2. Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan展开收起
129
天
An outer membrane vesicle‐associated two‐track model for enterotoxigenic Bacteroides fragilis oncogenesis
作者
Kangchan Choi; Sang‐Hyeon Yoo; Ki‐Jong Rhee展开收起
作者单位
1. Regeneration Medicine Research Center Yonsei University Wonju College of Medicine Republic of Korea; 2. School of Medicine Trinity Medical Sciences University Kingstown Saint Vincent and the Grenadines; 3. Department of Biomedical Laboratory Science, College of Health Sciences, MIRAE Campus Yonsei University Wonju Republic of Korea展开收起
158
天
Overcoming platinum resistance by the disulfiram metabolite CuET in novel preclinical models of human carcinomas
作者
Stefanos Arampatzis; Tereza Buchtová; Jirina Bartkova; Marie Lund Bay; Christoffer Lynge Halvorsen; Zuzana Machacova; Zdenek Skrott; Martin Mistrik; Ekaterina Dulina; Miguel Andujar‐Sanchez; Estrid Høgdall; Tine Henrichsen Schnack; Claus Høgdall; Berit Jul Mosgaard; Marie Boennelycke; Jacob Brink Laursen; Allan Jensen; Susanne K. Kjær; Tuula Kallunki; Robert Strauss; Jiri Bartek展开收起
作者单位
1. Genome Integrity Group Danish Cancer Institute, Danish Cancer Society Copenhagen Denmark; 2. Division of Genome Biology, Department of Medical Biochemistry and Biophysics, Science for Life Laboratory Karolinska Institute Stockholm Sweden; 3. Cancer Invasion and Resistance Group Danish Cancer Institute, Danish Cancer Society Copenhagen Denmark; 4. Faculty of Medicine and Dentistry Institute of Molecular and Translational Medicine, Palacky University Olomouc Czech Republic; 5. Department of Pathology Complejo Hospitalario Universitario Insular Las Palmas Gran Canaria Spain; 6. Molecular Unit, Department of Pathology Copenhagen University Hospital, Herlev and Gentofte Hospital Denmark; 7. Department of Gynaecology Copenhagen University Hospital Rigshospitalet Denmark; 8. Department of Clinical Medicine University of Copenhagen Denmark; 9. Department of Pathology Copenhagen University Hospital Rigshospitalet Denmark; 10. Virus, Lifestyle and Genes Group Danish Cancer Institute, Danish Cancer Society Copenhagen Denmark; 11. Translational and Clinical Pharmacology, Department of Drug Design and Pharmacology University of Copenhagen Denmark; 12. Division of Cancer Research, Ninewells Hospital and Medical School University of Dundee UK展开收起
191
天
85
天
Optimization of seminal extracellular vesicle isolation protocols for cancer biomarker analysis using proteomic profiling
作者
Elen Telumyan; Beatriz Martín‐Gracia; Eva Bassols‐Citores; Krizia Sagini; Maria K. Andersen; Tuula A. Nyman; May‐Britt Tessem; Morten B. Rye; Alicia Llorente展开收起
作者单位
1. Department of Circulation and Medical Imaging NTNU Trondheim Norway; 2. Department of Molecular Cell Biology, Institute for Cancer Research Oslo University Hospital‐The Norwegian Radium Hospital Oslo Norway; 3. Centre for Cancer Cell Reprogramming, Faculty of Medicine University of Oslo Norway; 4. Department of Immunology University of Oslo and Oslo University Hospital Norway; 5. Clinic of Surgery, St. Olavs Hospital Trondheim University Hospital Norway; 6. Department of Clinical and Molecular Medicine NTNU Trondheim Norway展开收起
FAQ
Molecular Oncology审稿要多久?
截至2026-11-17,CrushSCI 收录了 Molecular Oncology 的 26 篇完整审稿记录。最快一篇从收稿到录用用了 2 天(Weakening the nuclear envelope: Lamin B receptor in melanoma metastasis,2026-05-04 收稿,2026-05-06 录用),最慢一篇用了 317 天;平均 135.8 天,中位数 133.5 天。最快这篇的日期间隔异常短,建议点开原文核对。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
